Bio

Dr. Ramaswamy is the Co-Founder and CEO of Kriya Therapeutics, a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy. Kriya aims to revolutionize how gene therapies are designed, developed, and manufactured - improving speed to market and delivering significant reductions in the cost per dose. The company is advancing a deep and diversified pipeline of innovative gene therapies spanning multiple therapeutic verticals, with current pipeline programs addressing metabolic, ophthalmic, and oncologic diseases. Previously, Dr. Ramaswamy was part of the early foundational team at Roivant Sciences, where he was responsible for helping to identify and evaluate assets across therapeutic areas and launch its first public subsidiary company. He went on to be the Chief Business Officer of Axovant Gene Therapies. Dr. Ramaswamy holds a medical degree from Brown University and an undergraduate degree in economics from Harvard University.